Teva to present at BofA Health Care Conference on May 12, highlighting R&D and future plans.

Teva Pharmaceutical Industries announced that Eric Hughes, EVP of Global R&D & Chief Medical Officer, will present at the BofA Securities Health Care Conference on May 12, 2026. The presentation will cover Teva's innovative biopharmaceutical developments and strategic plans, reflecting its commitment to advancing health through neuroscience, immunology, generics, and biosimilars. This event offers investors insight into Teva's growth strategy and pipeline progress. The presentation will be webcast live and archived for 30 days on Teva's investor relations website.